This Smithfield Foods Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.

Barclays analyst Benjamin Budish initiated coverage on Blue Owl Capital Inc. OWL with an Overweight rating and announced a price target of $29. Blue Owl Cap shares closed at $22.13 on Friday. See how other analysts view this stock.
Citigroup analyst Thomas Palmer initiated coverage on Smithfield Foods, Inc. SFD with a Buy rating and announced a price target of $27. Smithfield Foods shares closed at $21.10 on Friday. See how other analysts view this stock.
Leerink Partners analyst Mike Kratky initiated coverage on Beta Bionics, Inc. BBNX with an Outperform rating and announced a price target of $28. Beta Bionics shares closed at $20.57 on Friday. See how other analysts view this stock.
Guggenheim analyst Michael Schmidt initiated coverage on Compass Therapeutics, Inc. CMPX with a Buy rating and announced a price target of $12. Compass Therapeutics shares closed at $2.92 on Friday. See how other analysts view this stock.
LifeSci Capital analyst Jimmy Shan initiated coverage on Tourmaline Bio, Inc. TRML with an Outperform rating and announced a price target of $58. Tourmaline Bio shares closed at $12.21 on Friday. See how other analysts view this stock.

Considering buying SFD stock? Here’s what analysts think:

Start Futures Trading Fast — with a $200 Bonus

Join Plus500 today and get up to $200 to start trading real futures. Practice with free paper trading, then jump into live markets with lightning-fast execution, low commissions, and full regulatory protection.